Related Experiment Videos
The role of T cells in Kawasaki disease
1William S. Rowe Division of Rheumatology, Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Insights
Kawasaki disease (KD) is a leading cause of pediatric heart disease. Research into T cell involvement in KD suggests diverse triggers, potentially including superantigens or conventional antigens, rather than a single cause.
Area of Science:
- Immunology
- Pediatric Cardiology
- Rheumatology
Background:
- Kawasaki disease (KD) is the most common pediatric vasculitis.
- It is a leading cause of acquired heart disease in children.
- The exact cause of KD remains unknown, but immune cells like T cells are implicated.
Purpose of the Study:
- To clarify the unclear role of T cells in Kawasaki disease pathogenesis.
- To reconcile conflicting data on T cell activation markers in KD.
- To investigate potential etiologic agents involved in KD.
Main Methods:
- Analysis of T-cell activation markers in peripheral blood.
- Limited studies examining tissue samples from KD patients.
- Review of existing literature on T cell receptor (V beta) expansions.
Main Results:
- Peripheral blood T cell marker data is conflicting.
- Some studies report V beta expansions, suggesting superantigen involvement.
- Other studies suggest conventional antigens may be involved.
Conclusions:
- The precise role of T cells in Kawasaki disease is still unclear.
- Evidence suggests that KD may be triggered by various etiologic agents.
- Further research, including tissue sample analysis, is needed to elucidate KD pathogenesis.
Abstract:
Kawasaki disease (KD) is the most common pediatric vasculitis and the most frequent cause of acquired heart disease in children in the U.S. Its etiopathogenesis is unknown, although T cell, B cell and monocyte/macrophage populations have all been implicated in the disease. The precise role played by T cells is unclear. Analysis of T-cell activation markers in peripheral blood has demonstrated conflicting data. Study of tissue samples, which could clarify this issue, has been limited. Expansion of T cells bearing V beta 2 and V beta 8 has been reported during the acute phase of the disease, suggesting that exposure to a superantigen may represent one of the etiologies. Other studies, however, have not confirmed V beta expansions of T cells; in fact, indirect evidence that a conventional antigen may be involved has been reported in certain patients. Together, these various studies suggest that the clinical entity of KD may be induced by a variety of etiologic agents.